Review of current guidelines for the management of women with vaginal discharge

1. Роговская С.И., Липова Е.В., ред. Шейка матки, влагалище, вульва. Физиология, патология, кольпоскопия, эстетическая коррекция. Руководство для практикующих врачей. М.: StatusPraesens; 2014: 34-43. [Rogovskaya S.I., Lipova E.V., ed. The cervix, vagina, vulva. Physiology, pathology, colposcopy, aesthetic correction. A guide for practitioners. M.: StatusPraesens; 2014: 34-43. (in Russian)].
2. Klebanoff M.A., Nansel T.R., Brotman R.M., Zhang J., Yu K.F., Schwebke J.R., Andrews W.W. Personal hygienic behaviors and bacterial vaginosis. Sex. Transm. Dis. 2010; 37(2): 94-9.
3. Workowski K.A., Bolan G.A., Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines. MMWR Recomm Rep 2015; 64(3): 69-72.
4. Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. European (IUSTI/WHO) Guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 1258-72.
5. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М.: Российское общество акушеров-гинекологов; 2019. 56 с. [Clinical recommendations for the diagnosis and treatment of diseases involving pathological secretions from the genital tract of women. M.: Russian Society of Obstetricians and Gynecologists; 2019. 56 p. (in Russian)].
6. Donders G.G., Ruban K., Bellen G. Selecting anti-microbial treatment of aerobic vaginitis. Curr. Infect. Dis. Rep. 2015; 17(5): 477.
7. Donders G.G., Zodzika J., Rezeberga D. Treatment of bacterial vaginosis: what we have and what we miss. Expert Opin. Pharmacother. 2014; 15(5): 645-57.
8. Verstraelen H., Swidsinski A. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Curr. Opin. Infect. Dis. 2013; 26: 86-9.
9. Kelly C.G., Younson J.S. Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces. Expert Opin. Investig. Drugs. 2009; 9(8): 1711-21.
10. Asadi A., Razavi S., Talebi M., Gholami M. A review on anti-adhesion therapies of bacterial diseases. Infection. 2019; 47: 25-6.
11. Van Dijk W. Further characterization of negatively charged polysaccharides isolated from concentrated Aloe vera gel with regard to antibacterial properties and molecular structure. Phytomedicine. 2006; 16(9): 856-63.Dermatological report on human patch test with 2QR-complex (batch 2011002374). World J. Gastroenterol. 2012; 18: 2026-34.
12. Eurofins. Cytotoxicity-Direct contact on 2QR-complex 0.8 mg/g report 2012/545-1. Curr. Med. Chem. 2012; 17: 129-38.
13. Bojovic T., Bojovic D., Boyer de La Tour F.-X., Lamers B. First line treatment and relief of bacterial vaginosis-related vaginal complaints with metronidazole and Multi-Gyn® ActiGel. Eur. Obstet. Gynaecol. 2012; 7(2): 103-6.
14. Балан В.Е., Тихомирова Е.В., Овчинникова В.В. Рецидивирующий бактериальный вагиноз – возможность увеличения продолжительности ремиссии. Акушерство и гинекология. 2017; 1: 83-8. [Balan V.E., Tikhomirova E.V., Ovchinnikova V.V. Recurrent bacterial vaginosis – the possibility of increasing the duration of remission. Obstetrics and gynecology. 2017; 1: 83-8. (in Russian)].
15. Dols J.A.M., Boon M.E. An in vitro study of the effects of self care Gels on desirable and undesirable vaginal microbiota. Eur. Obstet. Gynaecol. 2012; 7(2): 107-10.
16. Palacios S., Nappi R.E., Bruyniks N., Particco M., Panay N. The European Vulvovaginal Epidemiological Survey (EVES): prevalence, symptoms and impact of vulvovaginal atrophy of menopause. Climacteric. 2018; 21(3): 286-91.Gliniewicz K., Schneider G.M., Ridenhour B.J., Williams C.J., Song Y., Farage M.A. et al. Comparison of the vaginal microbiomes of premenopausal and postmenopausal women. J. Front. Microbiol. 2019; 10: Article 193.
17. Mason M.J., Winter A.J. How to diagnose and treat aerobic and desquamative inflammatory vaginitis. Sex. Transm. Infect. 2017; 93: 8-10.
18. Bruyniks N., Biglia N., Palacios S., Mueck A.O. Systematic indirect comparison of ospemifene versus local estrogens for vulvar and vaginal atrophy. Climacteric. 2017; 20(3): 195-204.
19. Gaspar A., Brandi H., Gomez V., Luque D. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg. Med. 2017; 49(2): 160-8.
20. Gambacciani M., Palacios S. Laser therapy for the restoration of vaginal function. Maturitas. 2017; 99: 10-5.
21. Балан В.Е. Урогенитальные расстройства в климактерии (клиника, диагностика, заместительная гормонотерапия): дисс. … д-ра мед. наук. М.; 295 с. [Balan V.E. Urogenital disorders in menopause (clinic, diagnosis, hormone replacement therapy): Diss. ... Dr. med sciences. M.; 295 p.(in Russian)].
22. Edwards D., Panay N. Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climateric. 2016; 19(2): 151-61.
23. Chatsiproios D., Schmidts-Winkler I.M., König L., Masur C., Abels C. Topical treatment of vaginal dryness with a non-hormonal cream in women undergoing breast cancer treatment – An open prospective multicenter study. PLoS One. 2019; 14(1): e0210967.
24. Kim Y.H., Park S., Lee M., Hahn S., Jeon M.J. Effect of a pH-balanced vaginal gel on dyspareunia and sexual function in breast cancer survivors who were premenopausal at diagnosis: a randomized controlled trial. Obstet. Gynecol. 2017; 129(5): 870-6.
25. Vermani K., Garg S., Zaneveld L.J. Assemblies for in vitro measurement of bioadhesive strength and retention characteristics in simulated vaginal environment. Drug Dev. Ind. Pharm. 2002; 28(9): 1133-46.

Received 12.04.2019

Accepted 19.04.2019